Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
77.21
+0.33 (0.43%)
May 16, 2025, 10:26 AM - Market open
Edwards Lifesciences Market Cap
Edwards Lifesciences has a market cap or net worth of $45.29 billion as of May 16, 2025. Its market cap has decreased by -12.47% in one year.
Market Cap
45.29B
Enterprise Value
42.13B
1-Year Change
-12.47%
Ranking
Category
Stock Price
$77.21
Market Cap Chart
Since March 27, 2000, Edwards Lifesciences's market cap has increased from $958.50M to $45.29B, an increase of 4,625.24%. That is a compound annual growth rate of 16.57%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 14, 2025 | 45.02B | 3.11% |
Dec 31, 2024 | 43.66B | -5.51% |
Dec 29, 2023 | 46.21B | 0.17% |
Dec 30, 2022 | 46.13B | -42.97% |
Dec 31, 2021 | 80.88B | 42.25% |
Dec 31, 2020 | 56.86B | 16.86% |
Dec 31, 2019 | 48.66B | 51.96% |
Dec 31, 2018 | 32.02B | 34.25% |
Dec 29, 2017 | 23.85B | 19.05% |
Dec 30, 2016 | 20.03B | 17.59% |
Dec 31, 2015 | 17.04B | 25.03% |
Dec 31, 2014 | 13.63B | 89.40% |
Dec 31, 2013 | 7.19B | -30.86% |
Dec 31, 2012 | 10.41B | 29.03% |
Dec 30, 2011 | 8.06B | -12.62% |
Dec 31, 2010 | 9.23B | 87.85% |
Dec 31, 2009 | 4.91B | 60.64% |
Dec 31, 2008 | 3.06B | 17.27% |
Dec 31, 2007 | 2.61B | -4.23% |
Dec 29, 2006 | 2.72B | 10.05% |
Dec 30, 2005 | 2.47B | 0.91% |
Dec 31, 2004 | 2.45B | 37.56% |
Dec 31, 2003 | 1.78B | 16.52% |
Dec 31, 2002 | 1.53B | -6.49% |
Dec 31, 2001 | 1.64B | 57.15% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 669.77B |
Johnson & Johnson | 358.41B |
AbbVie | 332.26B |
Novo Nordisk | 292.03B |
UnitedHealth Group | 289.89B |
Abbott Laboratories | 225.76B |
Novartis AG | 213.30B |
AstraZeneca | 210.42B |